Kura Oncology to Participate in Two Upcoming Investor Conferences

NEXT STORY
Medical Tourism Market to Grow Steadily on Account of Active Government Promotion and Support: Fortune Business Insights
PREV STORY
Corbus Pharmaceuticals Announces Topline Results from RESOLVE-1 Phase 3 Study of Lenabasum for Treatment of Systemic Sclerosis
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cidara Provides Corporate Update and Reports Second Quarter 2018 Financial Results

SAN DIEGO, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a ...

author_avatar
NASDAQ Market News

Melinta Therapeutics Announces Appointment of John H. Johnson as Interim Chief Executive Officer

NEW HAVEN, Conn., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc., (NASDAQ: MLNT), ...

author_avatar
NASDAQ Market News

eFFECTOR Announces Appointment of John W. Smither to its Board of Directors

SAN DIEGO, March 23, 2018 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., a leader in ...

author_avatar
NASDAQ Market News